Your browser doesn't support javascript.
loading
Anti-TNF-α therapy reduces retinol-binding protein 4 serum levels in non-diabetic patients with psoriasis: a 6-month prospective study.
Pina, T; Genre, F; Lopez-Mejias, R; Armesto, S; Ubilla, B; Mijares, V; Dierssen-Sotos, T; Corrales, A; Gonzalez-Lopez, M A; Gonzalez-Vela, M C; Blanco, R; Llorca, J; Gonzalez-Gay, M A.
Afiliação
  • Pina T; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
  • Genre F; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
  • Lopez-Mejias R; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
  • Armesto S; Dermatology Division, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
  • Ubilla B; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
  • Mijares V; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
  • Dierssen-Sotos T; Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain.
  • Corrales A; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
  • Gonzalez-Lopez MA; Dermatology Division, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
  • Gonzalez-Vela MC; Pathology Division, Hospital Universitario Marques de Valdecilla, University of Cantabria, Santander, Spain.
  • Blanco R; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
  • Llorca J; Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain.
  • Gonzalez-Gay MA; Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
J Eur Acad Dermatol Venereol ; 30(1): 92-5, 2016 Jan.
Article em En | MEDLINE | ID: mdl-25650695

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Fator de Necrose Tumoral alfa / Proteínas Plasmáticas de Ligação ao Retinol / Adalimumab / Anti-Inflamatórios Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: J Eur Acad Dermatol Venereol Assunto da revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Fator de Necrose Tumoral alfa / Proteínas Plasmáticas de Ligação ao Retinol / Adalimumab / Anti-Inflamatórios Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: J Eur Acad Dermatol Venereol Assunto da revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha País de publicação: Reino Unido